This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

8 Stocks Hitting New 52-Week Highs


Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Vivus (VVUS - Get Report) is engaged in development and commercialization of therapeutic drugs for large underserved markets, including obesity and related morbidities, such as sleep apnea and diabetes and men's sexual health. This stock is trading up 0.6% at $12.85 in recent trading after hitting a 52-week high of $13.18 earlier in the day.

Today's Range: $12.70-$13.18

52-Week Range: $6.00-$12.84

Volume: 1.3 million

Three-Month Average Volume: 1.75 million

Vivus has a market cap of $1.15 billion and an enterprise value of $979.77 million. The stock trades at a price-to-book of 7.54. Its estimated growth rate for this year is 45.8%, and for next year it's pegged at 44.2%. The current short interest as a percentage of the float for VIVUS is rather high at 18.3%.

From a technical perspective, VVUS is starting to flirt with a major breakout trade today since the stock has started to move above near-term overhead resistance at $12.84 to $12.98 on decent volume. Market players should now watch for a sustained high-volume move and close above those levels to signal that VVUS wants to trend much higher.

Look for volume that's near or above 1.75 million shares if those levels are taken out. If we get that action soon, look for VVUS to re-test its 2010 high of $13.68, or possibly trade even higher.
4 of 9

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
AAPL $118.31 -0.48%
BUD $128.71 0.61%
LF $0.71 0.91%
LMT $225.54 -0.39%
MSFT $54.00 -0.47%


Chart of I:DJI
DOW 17,835.97 +23.78 0.13%
S&P 500 2,091.14 +2.00 0.10%
NASDAQ 5,117.9290 +15.1210 0.30%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs